Seattle (PRWEB) November 11, 2010
iGenix announced today that it has successfully completed Illumina CSPro™ certification for the BeadXpress, gaining entry to an elite group of Illumina genomics service providers globally. Illumina Inc., a San Diego-based company, provides leading-edge genetic analysis tools to genomics centers worldwide.
Illumina CSPro is the collaborative service provider partnership dedicated to ensuring the delivery of the highest-quality data available for genetic analysis applications. Illumina CSPro participants undergo a rigorous two-phase certification process that includes minimum data generation, data certification, and an on-site audit of the facility and processes.
“iGenix is announcing a new lab service this month focused on helping researchers understand the genetic variability associated with drug response and predisposition, the Illumina ADME panel,” said Dr. Tera Eerkes, CSO of iGenix. “Adding CSPro certification helps our customers know they are working with a trusted Illumina partner. We see huge potential working with Illumina to help drug developers accelerate their research process and bring new products to market.”
"Illumina CSPro recognizes organizations that provide customers with industry-leading data quality and service in genetic analysis," said Karen Possemato, Illumina's Sr. Director of Corporate Marketing. "We are excited to work with iGenix to make it easier for researchers to access high-quality services using Illumina's genetic analysis technologies."
About iGenix, Inc. - http://www.iGenixInc.com
Founded by Tera Eerkes Ph.D. and Dr. Carl Newman, M.D, in 2007, iGenix provides contract research and laboratory services to researchers and physicians seeking to understand the complex nature of disease. iGenix has particular expertise in biomarker evaluation, specifically helping clients develop new diagnostic assays suitable for the BeadXpress platform.
# # #